title: Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations.
abstract: BACKGROUND
  The search for the eight most frequent mutations (i.e., DeltaF508, G542X, W1282X, N1303K, 1717-1G-->A, R553X, 2183AA-->G, and I148T) by allele-specific oligonucleotide dot-blot analysis revealed 78% of 396 cystic fibrosis alleles in Southern Italy. The observation of frequent haplotypes on the unidentified cystic fibrosis alleles suggested that a few mutations could account for a large number of unidentified alleles.
  
  
  METHODS
  We screened most of the coding sequence of the cystic fibrosis transmembrane regulator gene by denaturing gradient gel electrophoresis to determine the spectrum of these mutations in 68 unrelated cystic fibrosis patients bearing one or both unidentified mutations.
  
  
  RESULTS
  The screening revealed five mutations, R1158X, 711+1G-->T, 4016insT, L1065P, and G1244E, each of which had a frequency of 1.3-1.8% (7% collectively). The 7% increase in the detection rate (85% vs 78%) reduces by >50% the residual risk of being cystic fibrosis carriers for couples who had tested negative by molecular analysis. We therefore designed a second allele-specific oligonucleotide set to analyze the five mutations. Among the patients analyzed, one patient homozygous for the L1065P mutation expressed a mild pulmonary and intestinal form of the disease with pancreatic insufficiency. Two other patients, homozygous for mutations R1158X and 4016insT, both expressed a severe cystic fibrosis phenotype.
  
  
  CONCLUSIONS
  Five cystic fibrosis mutations are peculiar to patients from Southern Italy. The method described for their analysis is efficient, inexpensive, and can be semi-automated by use of a robotic workstation. The results obtained in patients from Southern Italy may have an impact on laboratories in other countries, given the large migrations of populations from Southern Italy to other countries in the last two centuries.
authors.affiliation: Centro di Ingegneria Genetica scarl and Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli "Federico II", 80131 Naples, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Castaldo
authors.forename: A
authors.initials: A
authors.lastname: Fuccio
authors.forename: C
authors.initials: C
authors.lastname: Cazeneuve
authors.forename: L
authors.initials: L
authors.lastname: Picci
authors.forename: D
authors.initials: D
authors.lastname: Salvatore
authors.forename: V
authors.initials: V
authors.lastname: Raia
authors.forename: M
authors.initials: M
authors.lastname: Scarpa
authors.forename: M
authors.initials: M
authors.lastname: Goossens
authors.forename: F
authors.initials: F
authors.lastname: Salvatore
mesh_terms: D000328:Adult; D003550:Cystic Fibrosis / Q000235:genetics*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics*; D004586:Electrophoresis / Q000379:methods; D005820:Genetic Testing; D006720:Homozygote; D006801:Humans; D007558:Italy; D009154:Mutation; D010641:Phenotype
chemical_list: C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator